Fake versions of popular diabetes and weight loss drugs like semaglutides are circulating online, alarming the WHO and major pharmaceutical companies like Novo Nordisk and Eli Lilly.
The WHO urges healthcare professionals and the public to be vigilant, avoiding suspicious medications and reporting any concerns to the authorities to combat the rising issue of fake drugs.
Collection
[
|
...
]